Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The Pharmaceutical Studies Reader
| The Pharmaceutical Studies Reader |
| Autore | Sismondo Sergio |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York : , : John Wiley & Sons, Incorporated, , 2015 |
| Descrizione fisica | 1 online resource (296 pages) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | GreeneJeremy A |
| Collana | Wiley Blackwell Readers in Anthropology Ser. |
| Soggetto topico |
Pharmaceutical industry
Pharmacy -- Research |
| Soggetto genere / forma | Electronic books. |
| ISBN |
9781118896549
9781118488836 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Title Page -- Copyright Page -- Contents -- Acknowledgements -- Chapter 1 Introduction -- Why Study Pharmaceuticals? -- A Prehistory of Pharmaceutical Studies -- Key Themes in Pharmaceutical Studies -- Guide to this Volume -- Notes -- Part I Pharmaceutical Lives -- Chapter 2 The Pharmaceuticalisation of Society? A Framework for Analysis -- Introduction -- Definition, Delineation and Dynamics: What is Pharmaceuticalisation? -- Trends and Transformations -- Discussion -- References -- Chapter 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct-to-Consumer Advertising -- Remaking the Body at Risk -- Awareness Through Education -- Personalizing the Risk -- Motivation to Informing Self-diagnosis -- Convincing the Doctor, the Critical Moment -- Branded Compliance -- Conclusion -- Note -- References -- Part II New Drugs, Diseases, and Identities -- Chapter 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension -- Introduction -- Diuril in the Life of the Pharmaceutical Firm -- Attachment: Diuril Meets Hypertension -- Clinical Research as a Marketing Arena -- Public Relations and Popular Media -- "Ethical Marketing": The Detail Man and the Diuril Man -- Reception: Diuril and Hypertension in Practice -- Expanding the Ranks of the Treatable -- Detaching "Diuril" from Hypertension -- Notes -- Chapter 5 Dep®ession and Consum♀tion: Psychopharmaceuticals, Branding, and New Identity Practices -- Introduction -- Branded Identity and "Symbolic Mistakes": The New Social Lives of Pharmaceuticals -- Markets, Molecules and Meanings -- Sarafeminism? -- Premenstrual Dysphoric Disorder in the Making -- Symbolic Side Effects -- Marketing (and) Medical Turf: Symbolic Fallout -- Conclusions -- Notes -- References -- Chapter 6 BiDil: Medicating the Intersection of Race and Heart Failure -- Considering Heart Failure as a Disease Category.
BiDil's Contingent History: V-HeIT to A-HeIT -- Too High a Price? -- Pharmakon -- The Material-semiotic -- Conclusion -- Notes -- Works Cited -- Chapter 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction -- New Diagnoses for New Drugs: Creating a Market -- The Commodification of Continuing Medical Education -- The Celebrity of the 'Sex Expert': Media and the Commodification of Female Sexual Dysfunction -- Robust Pipelines -- Notes -- References -- Part III Drugs and the Circulation of Medical Knowledge -- Chapter 8 Following the Script: How Drug Reps Make Friends and Influence Doctors -- Better than You Know Yourself -- Script Tracking -- The Value of Samples -- Funding Friendship -- Conclusion -- References -- Chapter 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster -- From Schizophrenia to Complicated Moods: The Evolution of Zyprexa -- Marketing Channels and Synergistic Power: Conclusion -- Notes -- References -- Chapter 10 Pushing Knowledge in the Drug Industry: Ghost-Managed Science -- Introduction -- A Sample Manuscript -- Publication Planning 101/201: An Insider View of the Field -- Marketing -- Medical Journals -- Authorship and its Limits -- Creating Knowledge Through Mediation -- Changing Trajectories? -- Discussion -- Notes -- References -- Chapter 11 Transcultural Medicine: A Multi-Sited Ethnography on the Scientific-Industrial Networking of Korean Medicine -- A Brief Modern History of Korean Medicine and its Transformation -- KM Doctors' Global Experiences: Biographical Accounts -- Hybrid and Modernized Practice: The Production of Hybrid KM Treatments in the KM Clinic -- Laboratory Practice and the Scientization of Herbal Therapies -- Network of Networks: Industrialization Process of Herbal Medicine in the Purimed Company. Transcultural Medicine and Emergence of New Medical Assemblage in Global Power Relations -- Conclusion -- Notes -- References -- Part IV Political and Moral Economies of Pharmaceutical Research -- Chapter 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam -- Introduction -- Hormones in the Laboratory -- In Search of a Wild Yam -- The Birth of Syntex -- George Rosenkranz and the Study of Chemistry in Mexico -- Human Faces Beyond the Laboratories: Mexicans Search for Barbasco -- Carl Djerassi: Syntex, Cortisone, and an Amazing Mexican Yam -- Conclusion -- Notes -- References -- Chapter 13 "Ready-to-Recruit" or "Ready-to-Consent" Populations?: Informed Consent and the Limits of Subject Autonomy -- Recruitment and Informed Consent -- Analysis of Advertisements -- Participation and Informed Consent -- Conclusion -- Notes -- References -- Chapter 14 Clinical Trials Offshored: On Private Sector Science and Public Health -- Clinical Trial Environments -- Pharmaceutical Capital: Contract Research in Brief -- Constructing Global Subjects -- Keeping the Clinical Trial Market in Poland -- 'Pharmaceuticals are the New Gold' -- Notes -- References -- Chapter 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India -- The Indian Clinical Trials Landscape -- A Critique of the Global Biomedical Economy: Expropriation, Exploitation, and the Structural Violence of Biocapital -- Notes -- Part V Intellectual Property in Local and Global Markets -- Chapter 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories -- Introduction -- Public Health Policy and Local Production of Generic Drugs -- The Unpatentable Status of Drugs in Brazil from 1945 to 1996: A Licit Copying Regime -- Copying and Technological Learning. Copying and Pharmaceutical Innovations -- Conflict Between the Brazilian Health Ministry and International Laboratories: Negotiations on Prices and Compulsory Licences -- Conclusions -- Notes -- Chapter 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' Anti-Cancer Drug Glivec -- Novartis versus the Government of India -- Pharmaceutical Citizens versus Novartis -- Pharmaceutical Citizens Pro Novartis -- Give to the Poor to Take from the Rich -- Note -- References -- Chapter 18 Generic Medicines and the Question of the Similar -- A New Market? -- The Similar and the "Similar" -- Generics and the Social Studies of Science and Technology -- Notes -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910795813703321 |
Sismondo Sergio
|
||
| New York : , : John Wiley & Sons, Incorporated, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Pharmaceutical Studies Reader
| The Pharmaceutical Studies Reader |
| Autore | Sismondo Sergio |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York : , : John Wiley & Sons, Incorporated, , 2015 |
| Descrizione fisica | 1 online resource (296 pages) |
| Disciplina | 338.4/76151 |
| Altri autori (Persone) | GreeneJeremy A |
| Collana | Wiley Blackwell Readers in Anthropology Ser. |
| Soggetto topico |
Pharmaceutical industry
Pharmacy -- Research |
| Soggetto genere / forma | Electronic books. |
| ISBN |
9781118896549
9781118488836 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Title Page -- Copyright Page -- Contents -- Acknowledgements -- Chapter 1 Introduction -- Why Study Pharmaceuticals? -- A Prehistory of Pharmaceutical Studies -- Key Themes in Pharmaceutical Studies -- Guide to this Volume -- Notes -- Part I Pharmaceutical Lives -- Chapter 2 The Pharmaceuticalisation of Society? A Framework for Analysis -- Introduction -- Definition, Delineation and Dynamics: What is Pharmaceuticalisation? -- Trends and Transformations -- Discussion -- References -- Chapter 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct-to-Consumer Advertising -- Remaking the Body at Risk -- Awareness Through Education -- Personalizing the Risk -- Motivation to Informing Self-diagnosis -- Convincing the Doctor, the Critical Moment -- Branded Compliance -- Conclusion -- Note -- References -- Part II New Drugs, Diseases, and Identities -- Chapter 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension -- Introduction -- Diuril in the Life of the Pharmaceutical Firm -- Attachment: Diuril Meets Hypertension -- Clinical Research as a Marketing Arena -- Public Relations and Popular Media -- "Ethical Marketing": The Detail Man and the Diuril Man -- Reception: Diuril and Hypertension in Practice -- Expanding the Ranks of the Treatable -- Detaching "Diuril" from Hypertension -- Notes -- Chapter 5 Dep®ession and Consum♀tion: Psychopharmaceuticals, Branding, and New Identity Practices -- Introduction -- Branded Identity and "Symbolic Mistakes": The New Social Lives of Pharmaceuticals -- Markets, Molecules and Meanings -- Sarafeminism? -- Premenstrual Dysphoric Disorder in the Making -- Symbolic Side Effects -- Marketing (and) Medical Turf: Symbolic Fallout -- Conclusions -- Notes -- References -- Chapter 6 BiDil: Medicating the Intersection of Race and Heart Failure -- Considering Heart Failure as a Disease Category.
BiDil's Contingent History: V-HeIT to A-HeIT -- Too High a Price? -- Pharmakon -- The Material-semiotic -- Conclusion -- Notes -- Works Cited -- Chapter 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction -- New Diagnoses for New Drugs: Creating a Market -- The Commodification of Continuing Medical Education -- The Celebrity of the 'Sex Expert': Media and the Commodification of Female Sexual Dysfunction -- Robust Pipelines -- Notes -- References -- Part III Drugs and the Circulation of Medical Knowledge -- Chapter 8 Following the Script: How Drug Reps Make Friends and Influence Doctors -- Better than You Know Yourself -- Script Tracking -- The Value of Samples -- Funding Friendship -- Conclusion -- References -- Chapter 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster -- From Schizophrenia to Complicated Moods: The Evolution of Zyprexa -- Marketing Channels and Synergistic Power: Conclusion -- Notes -- References -- Chapter 10 Pushing Knowledge in the Drug Industry: Ghost-Managed Science -- Introduction -- A Sample Manuscript -- Publication Planning 101/201: An Insider View of the Field -- Marketing -- Medical Journals -- Authorship and its Limits -- Creating Knowledge Through Mediation -- Changing Trajectories? -- Discussion -- Notes -- References -- Chapter 11 Transcultural Medicine: A Multi-Sited Ethnography on the Scientific-Industrial Networking of Korean Medicine -- A Brief Modern History of Korean Medicine and its Transformation -- KM Doctors' Global Experiences: Biographical Accounts -- Hybrid and Modernized Practice: The Production of Hybrid KM Treatments in the KM Clinic -- Laboratory Practice and the Scientization of Herbal Therapies -- Network of Networks: Industrialization Process of Herbal Medicine in the Purimed Company. Transcultural Medicine and Emergence of New Medical Assemblage in Global Power Relations -- Conclusion -- Notes -- References -- Part IV Political and Moral Economies of Pharmaceutical Research -- Chapter 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam -- Introduction -- Hormones in the Laboratory -- In Search of a Wild Yam -- The Birth of Syntex -- George Rosenkranz and the Study of Chemistry in Mexico -- Human Faces Beyond the Laboratories: Mexicans Search for Barbasco -- Carl Djerassi: Syntex, Cortisone, and an Amazing Mexican Yam -- Conclusion -- Notes -- References -- Chapter 13 "Ready-to-Recruit" or "Ready-to-Consent" Populations?: Informed Consent and the Limits of Subject Autonomy -- Recruitment and Informed Consent -- Analysis of Advertisements -- Participation and Informed Consent -- Conclusion -- Notes -- References -- Chapter 14 Clinical Trials Offshored: On Private Sector Science and Public Health -- Clinical Trial Environments -- Pharmaceutical Capital: Contract Research in Brief -- Constructing Global Subjects -- Keeping the Clinical Trial Market in Poland -- 'Pharmaceuticals are the New Gold' -- Notes -- References -- Chapter 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India -- The Indian Clinical Trials Landscape -- A Critique of the Global Biomedical Economy: Expropriation, Exploitation, and the Structural Violence of Biocapital -- Notes -- Part V Intellectual Property in Local and Global Markets -- Chapter 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories -- Introduction -- Public Health Policy and Local Production of Generic Drugs -- The Unpatentable Status of Drugs in Brazil from 1945 to 1996: A Licit Copying Regime -- Copying and Technological Learning. Copying and Pharmaceutical Innovations -- Conflict Between the Brazilian Health Ministry and International Laboratories: Negotiations on Prices and Compulsory Licences -- Conclusions -- Notes -- Chapter 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' Anti-Cancer Drug Glivec -- Novartis versus the Government of India -- Pharmaceutical Citizens versus Novartis -- Pharmaceutical Citizens Pro Novartis -- Give to the Poor to Take from the Rich -- Note -- References -- Chapter 18 Generic Medicines and the Question of the Similar -- A New Market? -- The Similar and the "Similar" -- Generics and the Social Studies of Science and Technology -- Notes -- References -- Index -- EULA. |
| Record Nr. | UNINA-9910810312203321 |
|
Sismondo Sergio
|
||
| New York : , : John Wiley & Sons, Incorporated, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||